NFA
SGMO

Nationwide Fund Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nationwide Fund Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-44,892
Closed -$673K – 1742
2017
Q3 		$673K Buy
44,892
+5,337
+13% +$59K ﹤0.01% 2020
2017
Q2 		$348K Hold
39,555
– – ﹤0.01% 2364
2017
Q1 		$206K Sell
39,555
-4,834
-11% -$19.4K ﹤0.01% 2572
2016
Q4 		$135K Hold
44,389
– – ﹤0.01% 2769
2016
Q3 		$206K Hold
44,389
– – ﹤0.01% 2605
2016
Q2 		$257K Hold
44,389
– – ﹤0.01% 2496
2016
Q1 		$269K Sell
44,389
-1,894
-4% -$11.4K ﹤0.01% 2402
2015
Q4 		$423K Buy
46,283
+1,165
+3% +$8.98K ﹤0.01% 2192
2015
Q3 		$254K Hold
45,118
– – ﹤0.01% 2451
2015
Q2 		$500K Sell
45,118
-4,648
-9% -$59.9K ﹤0.01% 2246
2015
Q1 		$780K Sell
49,766
-1,859
-4% -$28.8K ﹤0.01% 2016
2014
Q4 		$785K Sell
51,625
-633
-1% -$7.69K ﹤0.01% 1930
2014
Q3 		$564K Sell
52,258
-72
-0.1% -$940 ﹤0.01% 2139
2014
Q2 		$799K Buy
52,330
+3,421
+7% +$49.2K ﹤0.01% 2011
2014
Q1 		$884K Buy
48,909
+1,807
+4% +$34.8K ﹤0.01% 1794
2013
Q4 		$654K Buy
47,102
+2,357
+5% +$27.1K ﹤0.01% 2111
2013
Q3 		$469K Buy
44,745
+275
+0.6% +$2.73K ﹤0.01% 2255
2013
Q2 		$347K Buy
+44,470
New +$388K ﹤0.01% 2214

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nationwide Fund Advisors's SGMO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2017, closing a stake of 44,892 shares — an estimated $673K sold.

Nationwide Fund Advisors first reported a position in SGMO in Q2 2013 and held it in 18 quarters. The position peaked at $884K in Q1 2014. 170 funds tracked by Wall St. Rank hold SGMO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 44,892 SANGAMO THERAPEUTICS INC shares in Q4 2017, an estimated $673K.
  • Nationwide Fund Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's SANGAMO THERAPEUTICS INC position peaked at $884K in Q1 2014.
  • 170 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.